Sarah Rickwood
Market Access/ Views & Analysis/ Views and analysis
Nine for 2021: The COVID-19 legacy
Catherine Longworth
2021, COVID-19, IQVIA, Nine for 2021, pandemic, Sarah Rickwood
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Time to change the channel? The future for customer engagement models
mike.hammerton@pharmaphorum.com
commercial strategy, COVID-19, customer engagement, Multichannel, omnichannel, Sarah Rickwood
0 Comment
Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
A sea-change for pharma? Pandemic commercial models and launch
mike.hammerton@pharmaphorum.com
coronavirus, COVID-19, launch, Sarah Rickwood
0 Comment
Digital/ Market Access/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Nine for 2019: how did we do on our predictions, and what does this mean for 2020?
mike.smith@pharmaphorum.com
2019, biosimilars, Brexit, China, digital, gene therapies, M&A, NIne for 2019, pricing, Sarah Rickwood
0 Comment
Deep Dive/ Sales and Marketing/ Views & Analysis/ Views and analysis
How new technologies are creating new markets
mike.hammerton@pharmaphorum.com
Deep Dive: Sales and Marketing Innovation 2019, IQVIA, Sarah Rickwood
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
The changing face of pharma’s customer engagement
mike.hammerton@pharmaphorum.com
customer engagement, customers, Sarah Rickwood
0 Comment